Emily Nguyen, MD
Orthopaedic Surgery of the Spine · Portland, ORNPI 1225293285
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,645 of the $13,823 with a category attached, or 69.8%. 12 manufacturers reported payments, led by Globus Medical at 36.7% of the total. Reporting peaked in 2024 at $4,629 and has fallen 97.0% since, to $138 in 2025.
Across 78 payments — averaging $177.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$5K
- Cerapedics Inc.$5K
- Steelhead Surgical Inc$2K
- Arthrex$1K
- Xtant Medical Inc$88
- Johnson & Johnson$74
- plus $149 from 6 others
What the payments were for
- Consulting fees$1,50011%
- Travel & lodging$9,64570%
- Food & beverage$2,50218%
- Education$1761%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 20 | $5,078 |
| Cerapedics Inc. | 18 | $4,760 |
| Steelhead Surgical Inc | 12 | $2,397 |
| Arthrex | 17 | $1,277 |
| Xtant Medical Inc | 1 | $88 |
| Johnson & Johnson(2 entities) | 4 | $74 |
| DJO, LLC | 1 | $44 |
| Nalu Medical, Inc. | 1 | $31 |
| Surgalign Spine Technologies, Inc. | 1 | $30 |
| Si-bone, Inc. | 1 | $16 |
| Biogen | 1 | $15 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$4,541
- Excelsius - GPS$1,760
- ExcelsiusGPS Robotic Navigation System$1,417
- Spine$1,301
- ELSA$297
- Excelsius Robotics System$102
How this compares
$13,823 in reported general payments places this provider in the 65th percentile of 22 orthopaedic surgery of the spine providers in Oregon.
See all orthopaedic surgery of the spine providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 153 | $3,206 |
| Pregabalin | 244 | $3,030 |
| Oxycodone Hcl | 95 | $673 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $444 |
| Meloxicam | 81 | $419 |
| Tramadol Hcl | 104 | $414 |
| Diazepam | 65 | $222 |
| Methylprednisolone | 16 | $120 |
| Cyclobenzaprine Hcl | 28 | $115 |
| Hydromorphone Hcl | 13 | $92 |
| Tizanidine Hcl | 19 | $59 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Portland
- Clifford LinPortland$33K
- Mark ManosoPortland$6K
- George OjiPortland$6K
- Jung YooPortland$3K
- Jonathan KarkPortland$2K
- Travis PhilippPortland$1K
- Andy KranenburgMedford$1.6M
- Mark PetersonMedford$902K
- Adam CabaloMedford$532K
- Robert TatsumiTualatin$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.